Document Detail


Efficacy and safety of nicorandil therapy in patients with acute heart failure.
MedLine Citation:
PMID:  20832994     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Nicorandil is a vasodilator that both opens potassium channels and has nitrate effects. The administration of nitrate is the gold standard for the treatment of acute heart failure (AHF). However, there have been few reports regarding the usefulness of nicorandil for the treatment of AHF. Therefore, we evaluated the efficacy of intravenous administration of nicorandil in patients with AHF.
METHODS: A total of 31 AHF patients were enrolled, and randomized into either the nicorandil group (n=16) or control group (n=15). Nicorandil was started with a bolus injection of 100 μg/kg, and the continuous injection of 60-100 μg/kg/h within 30 min after admission, which continued for 5 days. There were no limitations in the treatment of AHF except for nicorandil use. B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NT-pro-BNP) were measured on admission (Day 1), Day 3, and Day 7.
RESULTS: BNP significantly decreased in the nicorandil group on Day 3 (502.4 ± 406.9 pg/ml) from Day 1 (1397.0 ± 1617.5 pg/ml), however, no significant decrease was observed in the control group. NT-pro-BNP tended to decrease on Day 3 (7316.7 ± 10,187.5 pg/ml, p=0.06) and significantly decreased on Day 7 (5702.9 ± 6468.8 pg/ml) from Day 1 (11,270.0 ± 12,388.5 pg/ml) in the nicorandil group, however there were no changes in the control group. When patients from nicorandil group were classified into a high systolic blood pressure (SBP) group (baseline SBP >140 mm Hg, n=10) and low SBP group (baseline SBP <140 mmHg, n=6), a significant decrease was observed in SBP from Day 1 to Day 3 in both groups.
CONCLUSIONS: Intravenous administration of nicorandil can decrease serum cardiac stress markers, and was shown to be effective in AHF patients. Furthermore, nicorandil improved the hemodynamics in the patients with high SBP, and the drug could be safely administered to AHF patients with low SBP.
Authors:
Akihiro Shirakabe; Noritake Hata; Shinya Yokoyama; Takuro Shinada; Nobuaki Kobayashi; Kuniya Asai; Kyoichi Mizuno
Related Documents :
21485674 - Responses to dural puncture during institution of combined spinal-epidural analgesia: a...
15985514 - Impairment of skin microvascular reactivity in hypertension and uraemia.
16368364 - Complementary alternative medical therapies for heart surgery patients: feasibility, sa...
20015974 - Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension trea...
11792954 - Appendiceal versus ileal segment for antegrade continence enema.
24957164 - Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.
Publication Detail:
Type:  Journal Article     Date:  2010-09-15
Journal Detail:
Title:  Journal of cardiology     Volume:  56     ISSN:  1876-4738     ISO Abbreviation:  J Cardiol     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804703     Medline TA:  J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  339-47     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Division of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School, 1715 Kamagari, Inzai, Inzai, Chiba 270-1694, Japan. s6042@nms.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surgical management of persistent oromandibular dystonia of the temporalis muscle.
Next Document:  Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia.